Press Releases
-
Quotient Sciences Supports Crinetics Pharmaceuticals with Fully Integrated Pediatric Development and Clinical Testing Program
Crinetics Pharmaceuticals, a pharmaceutical company that develops therapies for rare endocrine diseases, and Quotient Sciences, a drug development and manufacturing accelerator, have announced a partnership to support Crinetics’ CRN04894 pediatric program.
Mar 29, 2023
-
Tower Cold Chain secures spot in Financial Times top 1000 fastest-growing companies
Temperature-controlled container specialist, Tower Cold Chain, has secured a position in the Financial Times annual list of Europe’s’ 1000 fastest-growing companies.
Mar 29, 2023
-
CRO Catawba Research Names Andrew Silverman, Ph.D., as COO
Catawba Research, a full-service contract research organization (CRO) for innovative trial management, is delighted to announce Andy Silverman, Ph.D., has joined its leadership team as its chief operating officer (COO).
Mar 29, 2023
-
MedPharm Announces Appointment of New U.S. Director of Analytical
MedPharm, a global CDMO specializing in topical and transdermal development and manufacturing, appoints new U.S. Director of Analytical and announces restructure of analytical suite.
Mar 29, 2023
-
Perovskites Quantum Dots and Display Technology
-
A Series of Colloidal Materials Newly Launched at Alfa Chemistry: Catalysts, Nanoparticles, and Silica
-
Pharmaceutical Testing on Tablet Fragility, Dissolution, and Disintegration
-
Main Ingredients of Cosmetics
-
1nHealth Launches Site Advisory Board to Prioritize Site Voice
1nHealth, a leading digital patient recruitment company, tapped industry experts to monitor and provide feedback to best optimize its ability to serve study sites.
Mar 27, 2023
-
Eluceda Develops ‘Two-Minute’ Covid Vaccine Authentication Test
Detection and anticounterfeit technology specialist Eluceda has developed a rapid, accurate and easy-to-use testing solution for detecting counterfeit Covid-19 vaccines in the field – providing a practical authentication solution that doesn’t require centralised testing infrastructure or specialised personnel.
Mar 27, 2023
-
Creative Biostructure Released Custom Hydrophobic Interaction Chromatography Service
-
Matexcel Updated Its Photovoltaic Product Analysis Service for Research Use
-
Abberior Installs State-of-the-Art STED Microscope at MBC BioLabs
Abberior has announced that they have placed a super-resolution STED microscope at MBC BioLabs, the leading San Francisco Bay Area biotech incubator network.
Mar 23, 2023
-
Headlands Research Deepens Diversity and Expands Network with Launch of Metro Detroit–Based Clinical Trial Site
Headlands Research, a network of clinical trial sites, announced that it recently launched a metro Detroit–based clinical research site, expanding clinical trial access to a large population that contributes to the overall diversity and representativeness of Headlands Research’s site network. Headlands Research Detroit is the second site to open following last year’s announcement of a multiyear initiative to launch several diversity-focused sites.
Mar 22, 2023
-
Citeline Finalist CluePoints Show Advanced AI Capabilities
Citeline Finalist CluePoints Show Advanced AI Capabilities RBQM leader shortlisted as a finalist for Citeline Award accolade in The Best Use of Artificial Intelligence in Clinical Trials category
Mar 22, 2023
-
Emmes Acquires Essex Management
-
Remedium and Exothera partner on scale-up and demonstration runs for AAV2-FGF18
Remedium Bio and Exothera S.A. reached an agreement for a collaboration to demonstrate the industrialization potential of Remedium’s AAV2-FGF18.
Mar 21, 2023
-
The Working Principle and Applications of Ion Exchange Resin
-
CD Formulation Supplies Active Ingredients, Antioxidants, and Chelating Chemicals for Cosmetic Industry
-
Sustainability takes centre stage for Tower Cold Chain at LogiPharma
Temperature-controlled specialist Tower is returning to LogiPharma in 2023 to showcase how pharmaceutical manufacturers are using its passive containers to improve their logistics infrastructure, in today’s sustainably inclined world.
Mar 20, 2023